Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis.
Cell Mol Immunol. 2019 Oct;16(10):820-832. doi: 10.1038/s41423-018-0184-y. Epub 2018 Nov 22.
Cell Mol Immunol. 2019.
PMID: 30467420
Free PMC article.
Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.
Babikr F, Wan J, Xu A, Wu Z, Ahmed S, Freywald A, Chibbar R, Wu Y, Moser M, Groot G, Zhang W, Zhang B, Xiang J.
Babikr F, et al.
Cell Mol Immunol. 2021 Dec;18(12):2632-2647. doi: 10.1038/s41423-021-00796-4. Epub 2021 Nov 15.
Cell Mol Immunol. 2021.
PMID: 34782757
Free PMC article.
Item in Clipboard
Cite
Cite